SB656933

Basic Information

CAS ID: 688763-64-6
Molecular Formula: C17H17Cl2FN4O4S
Molecular Weight: 463.3 g/mol
Monoisotopic Mass: 462.0332 g/mol
Class: Small Molecule
Natural Product: No
Other Names: SB-656933-AAF | SB-656933-AAA | ELUBRIXIN TOSYLATE | SB-656933 | ELUBRIXIN
Analysis: Drug repositioning mechanism analysis

OH NH O NH F Cl Cl S O O N NH

Compound Structure and Identifier

InChI: InChI=1S/C17H17Cl2FN4O4S/c18-10-4-5-13(23-17(26)22-12-3-1-2-11(20)14(12)19)15(25)16(10)29(27,28)24-8-6-21-7-9-24/h1-5,21,25H,6-9H2,(H2,22,23,26) See All
InChI Key: YQYFEGTYCUQBEI-UHFFFAOYSA-N
Smiles: Oc1c(NC(=O)Nc2cccc(F)c2Cl)ccc(Cl)c1S(=O)(=O)N3CCNCC3 See All
Molfile: Download

Related Target

Related Fibrosis Property

Trial Record 1

ClinicalTrial ID NCT00903201 Disease Cystic fibrosis
Phase Phase 2 Status Completed
First Received May 18, 2009 Last Verified November 17, 2017
Sponsor GlaxoSmithKline

Trial Record 2

ClinicalTrial ID NCT00605761 Disease Cystic fibrosis
Phase Phase 1 Status Completed
First Received January 31, 2008 Last Verified March 19, 2012
Sponsor GlaxoSmithKline

Trial Record 3

ClinicalTrial ID NCT00615576 Disease Cystic fibrosis
Phase Phase 1 Status Completed
First Received February 14, 2008 Last Verified August 8, 2017
Sponsor GlaxoSmithKline

Related Link

PubChem: 10479502
ChEMBL: CHEMBL2178579